Status:
ACTIVE_NOT_RECRUITING
Map of Tumor Genetic Actionability in Argentina
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Neoplasms Malignant
Biomarkers
Eligibility:
All Genders
18+ years
Brief Summary
The study of the human genome laid the foundations for the search for a large number of molecular alterations related to different diseases. The Precision medicine allows us to know molecular alterati...
Detailed Description
Platform Development A validation study of a new genetic panel of 52 genes will be carried out in tissue biopsies from adult subjects with the most prevalent solid tumors in Argentina. In a first pha...
Eligibility Criteria
Inclusion
- Subjects 18 years of age or older Subjects diagnosed with cancer due to solid tumors who have a sample of tissue from a previous surgery or biopsy that is sufficient to be able to carry out the study methodology.
- Subjects who agree to sign the informed consent
Exclusion
- Subjects who do not agree to sign the informed consent.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 22 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06995235
Start Date
April 1 2024
End Date
April 22 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1199ABB